RomSoft to Supply Blockchain Technology for PharmaLedger EU Project

We start the year at the kick-off PharmaLedger project meeting in Prague, a Horizon 2020 funded project where RomSoft will be the blockchain technology supplier.

We’ll be working alongside some of the biggest companies in the pharmaceutical industry, like Pfizer, Novartis, GSK, Novo Nordisk, Bayer, or Astra Zeneca.

RomSoft is responsible to develop the software needed for a larger, integrated system that, among other benefits, will help fight the huge market of counterfeit drugs. The blockchain technology can help reveal more effectively where vulnerabilities appear along the production and distribution chains.

PharmaLedger is a $ 20 million project (where $ 6 million represents the EU contribution and the difference is totalized by the individual contributions of the eight big-pharma project partners). The project duration is 36 months and RomSoft is one of the two technical partners in the consortium.

Alongside Novartis, we‘ll be technically coordinating the PharmaLedger blockchain, but also participate in the development of domain reference applications for the pharmaceutical industry (supply chain, clinical studies, and health data). These applications will be using blockchain data as a trust source.

Blockchain is an open, distributed ledger that can record transactions between two parties efficiently and in a verifiable and permanent way. Once data is added to the system it cannot be replaced, changed or stolen.